Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue

Organovo (ONVO) Issues Update on In Vitro 3-D Bioprinted Kidney Tissue

April 1, 2015 8:17 AM EDT

Organovo (NYSE: ONVO) presented data on the company's in vitro three-dimensional kidney tissue at the 2015 Experimental Biology conference in Boston, Massachusetts.

"Kidney represents an ideal extension of Organovo's capabilities to 3D bioprint organ tissues that can be tremendously useful in pharmaceutical research," said Keith Murphy, Chairman and Chief Executive Officer at Organovo. "The results released today admirably demonstrate a proof of concept that kidney is on the way to becoming another core commercial tissue for Organovo. The product that we intend to build from these initial results can be an excellent expansion for... More